GlassScriptPhysician profile
Viral V Patel
NPI 1003012428
$5,488.97
in general payments reported to CMS, 2019-2025
40 companies · $744 in 2025
The $744 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,028 · 2020: $299 · 2021: $633 · 2022: $982 · 2023: $1,092 · 2024: $711 · 2025: $744.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,547.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,230.54 | 2021-2025 | |
| Pfizer INC. | $551.35 | 2019-2025 | |
| Glaxosmithkline, LLC. | $386.64 | 2019-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $371.10 | 2019-2022 | |
| Novo Nordisk INC | $328.04 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Alphatec Spine, INC | $265.08 | 2023 | |
| Lilly USA, LLC | $252.32 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $216.44 | 2019-2025 | Airsupra |
| Amgen INC. | $213.49 | 2019-2025 | Otezla, Repatha, Evenity |
| Abbott Laboratories | $173.38 | 2021-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Regeneron Healthcare Solutions, INC. | $145.59 | 2022 | |
| Exact Sciences Corporation | $120.22 | 2023-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.41 | 2019-2025 | Xifaxan |
| Novartis Pharmaceuticals Corporation | $93.32 | 2019-2024 | |
| Allergan, INC. | $93.29 | 2019-2020 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Viral Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.